United States · 
Who invested in Cleave Therapeutics?
Cleave Therapeutics's investors include New Enterprise Associates, U.S. Venture Partners, OrbiMed, 5AM Ventures and M Ventures, and 4 more on record.
United States · Series C startup
Who invested in Cleave Therapeutics
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2019, from 1 source
- Latest round
- Series C, $12MAug 2019
- Investors
- 9
The rounds
- Aug 2019
Everyone who backed them
Arcus VenturesVC firm1round
Celgene CorporationInvestment firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Cleave Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Cleave Therapeutics
How much has Cleave Therapeutics raised?
Cleave Therapeutics has raised $12M across 1 round since 2019.
When did Cleave Therapeutics last raise?
Cleave Therapeutics's most recent round was a Series C of $12M in Aug 2019.
What was Cleave Therapeutics's biggest round?
Its most recent round, $12M in Aug 2019, is also its largest on record.
Who backed Cleave Therapeutics first?
Cleave Therapeutics's first round on record, in Aug 2019, was backed by New Enterprise Associates, U.S. Venture Partners and OrbiMed and 6 others.
What stage is Cleave Therapeutics at?
Cleave Therapeutics's latest named round is a Series C, in Aug 2019.
Where is Cleave Therapeutics based?
Cleave Therapeutics is based in the United States.
Companies like Cleave Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.